学术会议:紧随研究趋势 洞察学术热点 进入>
产业会议:新技术,新领域,深入产业环节 进入>
举办会议及论坛超过百场 邀请海内外院士超过50名 教授PI专家授课超过1000名 总参会人数超过10万人
2018-05-17至2018-05-19 上海
English
导航
报名参会
Sign up

已确认嘉宾Confirmed Guests

Li Zhou VP of Cell Engineering

TxCell France

Developing CAR Treg for Treating Autoimmune Disease

Li Zhou VP of Cell Engineering

演讲题目:Developing CAR Treg for Treating Autoimmune Disease

TxCell France

Li Zhou, PhD, is VP of Cell Engineering at Txcell in France. TxCell is dedicated to the developing CAR-Treg therapy for the treatment of autoimmune diseases. Under his leadership, the team quickly established a diversed CAR-Treg based portfolio for treating autoimmune disease and for prevention of organ transplant rejection. Prior to this, he was Chief Scientific Officer and Director of research at ZMKS International Cancer Therapy Biotechnologies Co., LTD in developing various CAR-T programs for solid tumor and blood caner. Before this, he was a lab head in Novartis Biologics Center in Cambridge working on developing bispecific therapeutics and CAR-T therapies in collaboration with Dr Carl June at UPenn. He led a number of CAR-T programs including CAR-T CD22 to treat CAR-T CD19 relapse due to antigen negative escape, and Mesothelin CAR T for solid tumor. Top candidates are currently in clinical development at Novartis. He also led the program on developing regulatable CAR-T and achieved proof of concept in the animal model.

邀请函

下载邀请函
×
留下姓名电话和邮箱,邀请函直接发送到邮箱
*姓名:
* 电话:
* Email: